Drug: rituximab Quarter: 2016Q3
Total Records: 1,104 Number of Pages: 56
DRUGNAME | PT | EventCount |
---|---|---|
rituximab | Mantle cell lymphoma | 4 |
RITUXIMAB | Meningitis tuberculous | 4 |
RITUXIMAB | Mixed dementia | 4 |
rituximab | Myositis | 4 |
RITUXIMAB | Neoplasm progression | 4 |
Rituximab | Nephrotic syndrome | 4 |
RITUXIMAB | Nervous system disorder | 4 |
Rituximab | Oedema | 4 |
Rituximab | Oral pain | 4 |
Rituximab | Osteonecrosis | 4 |
Rituximab | Pancreatitis | 4 |
Rituximab | Peripheral venous disease | 4 |
Rituximab | Peritoneal tuberculosis | 4 |
Rituximab | Pneumonia aspiration | 4 |
Rituximab | Pneumonia bacterial | 4 |
RITUXIMAB | Pneumonia klebsiella | 4 |
Rituximab | Pneumonitis | 4 |
Rituximab | Primary mediastinal large B-cell lymphoma recurrent | 4 |
Rituximab | Radicular pain | 4 |
Rituximab | Respiratory distress | 4 |
Total Records: 1,104 Number of Pages: 56